Merck & Co. Inc. (MRK) - Other Revenue (I:MCIMHUOR)
Level Chart
Basic Info
|
Merck & Co. Inc. (MRK) - Other Revenue is at a current level of 299.00M, up from 122.00M last quarter and down from 625.00M one year ago. This is a change of 145.1% from last quarter and -52.16% from one year ago. |
|
Other Revenue for Merck & Co. Inc. typically refers to the revenue generated by the company from sources other than its primary business segments, which are pharmaceuticals and animal health. This category may encompass a variety of income streams that are not directly related to drug development, manufacturing, or sales. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 299.00M |
| Latest Period | Sep 2023 |
| Last Updated | Jan 12 2024, 16:53 EST |
| Next Release | Apr 30 2024, 23:00 EDT (E) |
| Average Growth Rate | 0.44% |
| Value from Last Quarter | 122.00M |
| Change from Last Quarter | 145.1% |
| Value from 1 Year Ago | 625.00M |
| Change from 1 Year Ago | -52.16% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| September 30, 2023 | 299.00M |
| June 30, 2023 | 122.00M |
| March 31, 2023 | 275.00M |
| December 31, 2022 | 420.00M |
| September 30, 2022 | 625.00M |
| June 30, 2022 | 370.00M |
| March 31, 2022 | 312.00M |
| December 31, 2021 | 221.00M |
| Date | Value |
|---|---|
| September 30, 2021 | 241.00M |
| June 30, 2021 | -50.00M |
| March 31, 2021 | -29.00M |
| December 31, 2020 | -33.00M |
| September 30, 2020 | -5.00M |
| June 30, 2020 | 74.00M |
| March 31, 2020 | 188.00M |
| December 31, 2019 | 213.00M |
Basic Info
|
Merck & Co. Inc. (MRK) - Other Revenue is at a current level of 299.00M, up from 122.00M last quarter and down from 625.00M one year ago. This is a change of 145.1% from last quarter and -52.16% from one year ago. |
|
Other Revenue for Merck & Co. Inc. typically refers to the revenue generated by the company from sources other than its primary business segments, which are pharmaceuticals and animal health. This category may encompass a variety of income streams that are not directly related to drug development, manufacturing, or sales. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 299.00M |
| Latest Period | Sep 2023 |
| Last Updated | Jan 12 2024, 16:53 EST |
| Next Release | Apr 30 2024, 23:00 EDT (E) |
| Average Growth Rate | 0.44% |
| Value from Last Quarter | 122.00M |
| Change from Last Quarter | 145.1% |
| Value from 1 Year Ago | 625.00M |
| Change from 1 Year Ago | -52.16% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Related Securities
Related Indicators
| Merck & Co. Inc. (MRK) - Animal Health Revenue | 5.625B USD |
| Merck & Co. Inc. (MRK) - Animal Health Revenue | 1.40B USD |
| Merck & Co. Inc. (MRK) - Other Revenue | 907.00M USD |